Corgard and Pegasys drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Corgard (nadolol) and Pegasys (peginterferon alfa 2a). Common drug interactions include arterial stenosis among females and thrombocytopenia among males.

The phase IV clinical study analyzes what interactions people have when they take Corgard and Pegasys. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Corgard?

Corgard has active ingredients of nadolol. It is often used in high blood pressure. eHealthMe is studying from 3,342 Corgard users. Check the latest studies of Corgard.

What is Pegasys?

Pegasys has active ingredients of peginterferon alfa 2a. It is often used in hepatitis c. eHealthMe is studying from 57,446 Pegasys users. Check the latest studies of Pegasys.

On Jul, 13, 2026

16 people who take Corgard and Pegasys together, and have interactions are studied.

What are the common drug interactions of Corgard and Pegasys, by gender? *:

female:

Arterial stenosis (abnormal narrowing of the aortic valve in the heart)
Peripheral ischaemia (impaired circulation to an extremity)
Hepatocellular injury (liver injury)
Liver transplant
Transplant rejection (a transplant material is not worked)
Urinary tract infection
Anaemia (lack of blood)
Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
Drug eruption (adverse drug reaction of the skin)
Eosinophil count increased

male:

Thrombocytopenia (decrease of platelets in blood)
Anaemia (lack of blood)
Hepatic lesion
Hepatic neoplasm (liver tumour)
Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
Non-hodgkin's lymphoma (malignant (cancer) cells form in the lymph system)
Abdominal distension
Abdominal rigidity
Blood glucose decreased
Chest pain

What are the common drug interactions of Corgard and Pegasys, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Dyspnoea (difficult or laboured respiration)
Extrapyramidal disorder (involuntary muscle spasms in the face and neck)
Lung disorder (lung disease)
Vomiting

50-59:

Depression
Drug ineffective
Gallbladder disorder
Nausea (feeling of having an urge to vomit)
Pancreatic disorder
Thrombocytopenia (decrease of platelets in blood)
Hepatocellular injury (liver injury)
Liver transplant
Transplant rejection (a transplant material is not worked)
Urinary tract infection

60+:

Anaemia (lack of blood)
Hepatic neoplasm malignant (liver cancer)
Thrombocytopenia (decrease of platelets in blood)
Diffuse large b-cell lymphoma (cancer of b cells, a type of white blood cell)
Hepatic lesion
Hepatic neoplasm (liver tumour)
Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
Non-hodgkin's lymphoma (malignant (cancer) cells form in the lymph system)
Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)

What are the existing conditions these people have? *

Varices Oesophageal (enlarged and swollen veins at the bottom of the oesophagus, near the stomach): 1 person, 6.25%
Rashes (redness): 1 person, 6.25%
Mitral Valve Prolapse (heart's mitral valve doesn't work well): 1 person, 6.25%
Hepatitis B: 1 person, 6.25%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.25%
Back Pain: 1 person, 6.25%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Corgard and Pegasys?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously